Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) COO Michael Greenhalgh Sells 1,088 Shares of Stock

Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) COO Michael Greenhalgh sold 1,088 shares of the stock in a transaction on Wednesday, January 12th. The shares were sold at an average price of $15.69, for a total transaction of $17,070.72. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

Michael Greenhalgh also recently made the following trade(s):

  • On Monday, January 3rd, Michael Greenhalgh sold 1,100 shares of Tabula Rasa HealthCare stock. The stock was sold at an average price of $15.67, for a total transaction of $17,237.00.

Shares of Tabula Rasa HealthCare stock opened at $15.02 on Friday. The company has a debt-to-equity ratio of 5.15, a quick ratio of 1.27 and a current ratio of 1.35. The stock has a market capitalization of $386.30 million, a PE ratio of -3.90 and a beta of 1.05. Tabula Rasa HealthCare, Inc. has a 52-week low of $10.05 and a 52-week high of $69.31. The company has a 50-day simple moving average of $13.45 and a two-hundred day simple moving average of $27.21.

Tabula Rasa HealthCare (NASDAQ:TRHC) last announced its quarterly earnings results on Thursday, November 4th. The company reported ($0.04) EPS for the quarter, topping analysts’ consensus estimates of ($0.19) by $0.15. Tabula Rasa HealthCare had a negative net margin of 27.37% and a negative return on equity of 44.56%. The firm had revenue of $86.60 million during the quarter, compared to analyst estimates of $88.54 million. During the same period in the previous year, the business posted ($0.35) earnings per share. The business’s revenue for the quarter was up 22.8% on a year-over-year basis. As a group, equities research analysts forecast that Tabula Rasa HealthCare, Inc. will post -1.75 EPS for the current fiscal year.

TRHC has been the subject of several research analyst reports. Piper Sandler dropped their target price on shares of Tabula Rasa HealthCare from $41.00 to $13.00 and set a “neutral” rating for the company in a research report on Friday, November 5th. Jefferies Financial Group started coverage on shares of Tabula Rasa HealthCare in a research report on Wednesday, December 1st. They set a “hold” rating and a $13.00 price target for the company. Royal Bank of Canada lowered their price target on shares of Tabula Rasa HealthCare from $70.00 to $23.00 and set an “outperform” rating for the company in a research report on Monday, November 8th. Zacks Investment Research raised shares of Tabula Rasa HealthCare from a “sell” rating to a “hold” rating and set a $17.00 price target for the company in a research report on Friday, January 7th. Finally, SVB Leerink lowered their price target on shares of Tabula Rasa HealthCare from $40.00 to $23.00 and set a “market perform” rating for the company in a research report on Monday, November 8th. Seven investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat.com, Tabula Rasa HealthCare has an average rating of “Hold” and an average target price of $27.80.

Several hedge funds have recently made changes to their positions in TRHC. Spouting Rock Asset Management LLC grew its position in Tabula Rasa HealthCare by 7.5% during the second quarter. Spouting Rock Asset Management LLC now owns 4,888 shares of the company’s stock valued at $244,000 after buying an additional 340 shares during the period. PNC Financial Services Group Inc. grew its position in Tabula Rasa HealthCare by 54.2% during the second quarter. PNC Financial Services Group Inc. now owns 1,315 shares of the company’s stock valued at $66,000 after buying an additional 462 shares during the period. Price T Rowe Associates Inc. MD grew its position in Tabula Rasa HealthCare by 6.1% during the second quarter. Price T Rowe Associates Inc. MD now owns 8,825 shares of the company’s stock valued at $441,000 after buying an additional 509 shares during the period. Redmond Asset Management LLC grew its position in Tabula Rasa HealthCare by 7.5% during the third quarter. Redmond Asset Management LLC now owns 10,605 shares of the company’s stock valued at $278,000 after buying an additional 739 shares during the period. Finally, FORA Capital LLC bought a new stake in Tabula Rasa HealthCare during the second quarter valued at approximately $40,000. Hedge funds and other institutional investors own 85.31% of the company’s stock.

Tabula Rasa HealthCare Company Profile

Tabula Rasa Healthcare, Inc is a healthcare technology company, which engages in the development of solutions designed for pharmacists, providers, and patients to optimize medication regimens. It operates through the following segments: CareVention HealthCare and MedWise HealthCare. The CareVention HealthCare segment provides services, PACE, which is a center for Medicare & Medicaid services, or CMS, sponsored program providing medical and social services.

Featured Story: Exchange-Traded Funds (ETFs)

Insider Buying and Selling by Quarter for Tabula Rasa HealthCare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.